These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25215271)

  • 1. Diabetic kidney disease: from epidemiology to clinical perspectives.
    Park CW
    Diabetes Metab J; 2014 Aug; 38(4):252-60. PubMed ID: 25215271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and strategies for early detection and management of diabetic kidney disease.
    Radbill B; Murphy B; LeRoith D
    Mayo Clin Proc; 2008 Dec; 83(12):1373-81. PubMed ID: 19046557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical challenges in diagnosis and management of diabetic kidney disease.
    Stanton RC
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S3-21. PubMed ID: 24461728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management.
    Vora JP; Ibrahim HA; Bakris GL
    J Hum Hypertens; 2000; 14(10-11):667-85. PubMed ID: 11095158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes.
    Kim SS; Kim JH; Kim IJ
    Endocrinol Metab (Seoul); 2016 Jun; 31(2):245-53. PubMed ID: 27246284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.
    Tziomalos K; Athyros VG
    Rev Diabet Stud; 2015; 12(1-2):110-8. PubMed ID: 26676664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diabetic patient: renal insufficiency like other kidney failures?].
    Rossert J
    Nephrol Ther; 2006 May; 2 Suppl 3():S187-9. PubMed ID: 17370848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistive Index of Intrarenal Artery in Evaluation of Diabetic Nephropathy.
    Shirin M; Sharif MM; Gurung A; Datta A
    Bangladesh Med Res Counc Bull; 2015 Dec; 41(3):125-130. PubMed ID: 29870167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
    Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic nephropathy. An update.
    Reddi AS; Camerini-Davalos RA
    Arch Intern Med; 1990 Jan; 150(1):31-43. PubMed ID: 2404481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence and clinical characteristics of renal insufficiency in diabetic patients].
    Schwenger V; Müssig C; Hergesell O; Zeier M; Ritz E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1322-6. PubMed ID: 11719856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for diabetic nephropathy.
    Bruno S; Cattaneo D; Perico N; Remuzzi G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):747-71. PubMed ID: 16262561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complication in diabetic nephropathy.
    John S
    Diabetes Metab Syndr; 2016; 10(4):247-249. PubMed ID: 27389078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in early biomarkers of diabetic nephropathy.
    Zhang J; Liu J; Qin X
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):85-92. PubMed ID: 29561946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
    Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
    BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in early diabetic nephropathy: fueling the fire.
    Singh DK; Winocour P; Farrington K
    Nat Rev Endocrinol; 2011 Mar; 7(3):176-84. PubMed ID: 21151200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.